scholarly article | Q13442814 |
P2093 | author name string | Brian N Mathur | |
David M Lovinger | |||
P2860 | cites work | Coactivation of D1 and D2 dopamine receptors is required for long-term synaptic depression in the striatum | Q48446136 |
A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old mice | Q27324171 | ||
D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons | Q29615480 | ||
Dichotomous dopaminergic control of striatal synaptic plasticity | Q30493521 | ||
Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity | Q34487550 | ||
Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. | Q34521936 | ||
Dopamine-mediated regulation of corticostriatal synaptic plasticity. | Q36762821 | ||
Presynaptic modulation by endocannabinoids | Q37026723 | ||
The endocannabinoid system as a target for the treatment of motor dysfunction | Q37394164 | ||
Neurotransmitter roles in synaptic modulation, plasticity and learning in the dorsal striatum | Q37680104 | ||
Endocannabinoids as regulators of transient receptor potential (TRP) channels: A further opportunity to develop new endocannabinoid-based therapeutic drugs | Q37694608 | ||
Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia. | Q39801798 | ||
Dynamic changes of anandamide in the cerebrospinal fluid of Parkinson's disease patients | Q42167232 | ||
Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models | Q42508054 | ||
Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. | Q44102387 | ||
Regional changes in type 1 cannabinoid receptor availability in Parkinson's disease in vivo | Q44641132 | ||
Mechanisms for synapse specificity during striatal long-term depression. | Q45937925 | ||
Dopamine modulation of state-dependent endocannabinoid release and long-term depression in the striatum. | Q46279749 | ||
Dopamine-dependent long-term depression is expressed in striatal spiny neurons of both direct and indirect pathways: implications for Parkinson's disease. | Q48114419 | ||
P921 | main subject | striatum | Q1319792 |
endocannabinoids | Q10483908 | ||
P304 | page(s) | S132-4 | |
P577 | publication date | 2012-01-01 | |
P1433 | published in | Parkinsonism and Related Disorders | Q15762600 |
P1476 | title | Endocannabinoids in striatal plasticity | |
P478 | volume | 18 Suppl 1 |
Q47643855 | CB1-Dependent Long-Term Depression in Ventral Tegmental Area GABA Neurons: A Novel Target for Marijuana. |
Q42493834 | Calcium dynamics predict direction of synaptic plasticity in striatal spiny projection neurons |
Q38522769 | Cannabinoid-dopamine interactions in the physiology and physiopathology of the basal ganglia |
Q98288614 | Cannabinoids, Endocannabinoids and Sleep |
Q36768205 | Closing the gate in the limbic striatum: prefrontal suppression of hippocampal and thalamic inputs. |
Q38992136 | Deep brain stimulation of the subthalamic nucleus preferentially alters the translational profile of striatopallidal neurons in an animal model of Parkinson's disease |
Q33583792 | Endocannabinoids and striatal function: implications for addiction-related behaviours |
Q26851389 | Modeling intracellular signaling underlying striatal function in health and disease |
Q34614351 | Presynaptic long-term depression mediated by Gi/o-coupled receptors. |
Q39381131 | Synaptic functions of endocannabinoid signaling in health and disease |
Q48058857 | Using In Vitro Electrophysiology to Screen Medications: Accumbal Plasticity as an Engram of Alcohol Dependence. |
Q38428721 | Weeding out bad waves: towards selective cannabinoid circuit control in epilepsy |
Q92878129 | Δ-Tetrahydrocannabinol Increases Dopamine D1-D2 Receptor Heteromer and Elicits Phenotypic Reprogramming in Adult Primate Striatal Neurons |
Search more.